The FDA will host the second in a series of medical device sterilization town halls on Friday, January 26, 2024 from 12:00pm-1:00 pm ET. This session, “FDA Activities and Challenges…
The FDA will host the second in a series of medical device sterilization town halls on Friday, January 26, 2024 from 12:00pm-1:00 pm ET. This session, “FDA Activities and Challenges…
…and increased satisfaction among healthcare professionals. Current State-of-the-Art of AI in Surgery The current state-of-the-art of AI in surgery primarily revolves around AI-based diagnosis, pre-operative planning and predictive outcomes. AI…
…and increased satisfaction among healthcare professionals. Current State-of-the-Art of AI in Surgery The current state-of-the-art of AI in surgery primarily revolves around AI-based diagnosis, pre-operative planning and predictive outcomes. AI…
…Products within the FDA’s Center for Biologics Evaluation and Research. “The approval of a cell-based gene therapy for this condition using CRISPR/Cas9 technology reflects FDA’s continued commitment to supporting safe…
…Products within the FDA’s Center for Biologics Evaluation and Research. “The approval of a cell-based gene therapy for this condition using CRISPR/Cas9 technology reflects FDA’s continued commitment to supporting safe…
Blue Spark Technologies, a digital health company specializing in AI-powered remote patient monitoring (RPM) to support precision drug development, has appointed MaryAnne Rizk, Ph.D., a leader in drug development technological…
Blue Spark Technologies, a digital health company specializing in AI-powered remote patient monitoring (RPM) to support precision drug development, has appointed MaryAnne Rizk, Ph.D., a leader in drug development technological…
…disease. This more precise and personalized approach holds the promise of better patient outcomes and new levels of health care efficiency and effectiveness. References: [1]https://www.bcrf.org/breast-cancer-statistics-and-resources/#:~:text=Breast%20cancer%20is%20the%20most%20common%20cancer%20in%20women%20overall,140%20of%20184%20countries%20worldwide. [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328041/ [3]https://www.aha.org/aha-center-health-innovation-market-scan/2023-05-09-how-ai-improving-diagnostics-decision-making-and-care#:~:text=AI%20algorithms%20analyze%20a%20vast,patient%20over%20the%20next%20several. [4]https://www.sciencedirect.com/science/article/abs/pii/S1568494621008085#:~:text=For%20a%20favorable%20prognosis%20of,stained%20with%20Hematoxylin%20and%20Eosin [5]https://www.basscancercenter.com/cancer-blog/breast-cancer-follow-up-care-guidelines#:~:text=After%20completing%20your%20breast%20cancer,emotional%20and%20physical%20well%2Dbeing….
…disease. This more precise and personalized approach holds the promise of better patient outcomes and new levels of health care efficiency and effectiveness. References: [1]https://www.bcrf.org/breast-cancer-statistics-and-resources/#:~:text=Breast%20cancer%20is%20the%20most%20common%20cancer%20in%20women%20overall,140%20of%20184%20countries%20worldwide. [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328041/ [3]https://www.aha.org/aha-center-health-innovation-market-scan/2023-05-09-how-ai-improving-diagnostics-decision-making-and-care#:~:text=AI%20algorithms%20analyze%20a%20vast,patient%20over%20the%20next%20several. [4]https://www.sciencedirect.com/science/article/abs/pii/S1568494621008085#:~:text=For%20a%20favorable%20prognosis%20of,stained%20with%20Hematoxylin%20and%20Eosin [5]https://www.basscancercenter.com/cancer-blog/breast-cancer-follow-up-care-guidelines#:~:text=After%20completing%20your%20breast%20cancer,emotional%20and%20physical%20well%2Dbeing….
…#2: Learn Everything about your Device and Competitors Educating yourself on the subject device and its purpose is extremely important. Aim to seek a deep understanding of: Intended use and…
…#2: Learn Everything about your Device and Competitors Educating yourself on the subject device and its purpose is extremely important. Aim to seek a deep understanding of: Intended use and…
The FDA has announced the five winners of the Veterans Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge. They are: VHeartAI ZS Associates ADS DSS Cognizant Good HeartML D&D The…
The FDA has announced the five winners of the Veterans Cardiac Health and AI Model Predictions (V-CHAMPS) Challenge. They are: VHeartAI ZS Associates ADS DSS Cognizant Good HeartML D&D The…
…associate professor of neurology. “Now I have a rechargeable DBS therapy option with sensing technology allowing me to track a patient’s response to DBS and medications. I use this data…
…associate professor of neurology. “Now I have a rechargeable DBS therapy option with sensing technology allowing me to track a patient’s response to DBS and medications. I use this data…
…of Bangalore, India, Kesavan joins CitiusTech from PwC India, where he served as Partner, Advisory – Cloud Transformation. Previously, he worked for large-scale IT companies including Wipro and Tata Consultancy…
…of Bangalore, India, Kesavan joins CitiusTech from PwC India, where he served as Partner, Advisory – Cloud Transformation. Previously, he worked for large-scale IT companies including Wipro and Tata Consultancy…
